Calumet Specialty Products Stock Filter Stocks by Fundamentals
| CLMT Stock | USD 22.54 0.14 0.63% |
Calumet Specialty Products fundamentals help investors to digest information that contributes to Calumet Specialty's financial success or failures. It also enables traders to predict the movement of Calumet Stock. The fundamental analysis module provides a way to measure Calumet Specialty's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Calumet Specialty stock.
Calumet | Shares Owned by Institutions |
Calumet Specialty Current Valuation Drivers
We derive many important indicators used in calculating different scores of Calumet Specialty from analyzing Calumet Specialty's financial statements. These drivers represent accounts that assess Calumet Specialty's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Calumet Specialty's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 285.5M | 245.3M | 1.0B | 1.3B | 1.4B | 1.1B | |
| Enterprise Value | 1.6B | 1.5B | 2.6B | 3.0B | 3.6B | 1.9B |
Calumet Specialty ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Calumet Specialty's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Calumet Specialty's managers, analysts, and investors.Environmental | Governance | Social |
Calumet Specialty Institutional Holders
Institutional Holdings refers to the ownership stake in Calumet Specialty that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Calumet Specialty's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Calumet Specialty's value.| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 401.2 K | Tidal Investments Llc. | 2024-09-30 | 400 K | Bienville Capital Management, Llc | 2024-09-30 | 341.1 K | Royal Bank Of Canada | 2024-06-30 | 319 K | Ubs Group Ag | 2024-06-30 | 306.4 K | Barnett & Co Inc | 2024-09-30 | 279.3 K | Lpl Financial Corp | 2024-09-30 | 195.5 K | Brown Advisory Holdings Inc | 2024-09-30 | 185.6 K | Ing Groep Nv | 2024-09-30 | 171 K | Wasserstein Debt Opportunities Management Lp | 2024-09-30 | 6.9 M | Adams Asset Advisors Llc | 2024-09-30 | 5.3 M |
Calumet Fundamentals
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 3.96 B | ||||
| Shares Outstanding | 85.9 M | ||||
| Shares Owned By Insiders | 21.27 % | ||||
| Shares Owned By Institutions | 37.28 % | ||||
| Number Of Shares Shorted | 5.15 M | ||||
| Price To Earning | 286.67 X | ||||
| Price To Book | 19.32 X | ||||
| Price To Sales | 0.46 X | ||||
| Revenue | 4.18 B | ||||
| Gross Profit | 370.2 M | ||||
| EBITDA | 418.2 M | ||||
| Net Income | 47.1 M | ||||
| Cash And Equivalents | 50.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 2.19 B | ||||
| Current Ratio | 0.60 X | ||||
| Book Value Per Share | (7.83) X | ||||
| Cash Flow From Operations | (14.9 M) | ||||
| Short Ratio | 5.82 X | ||||
| Earnings Per Share | (2.82) X | ||||
| Price To Earnings To Growth | 2.71 X | ||||
| Target Price | 24.6 | ||||
| Number Of Employees | 1.58 K | ||||
| Beta | 1.91 | ||||
| Market Capitalization | 1.94 B | ||||
| Total Asset | 2.75 B | ||||
| Retained Earnings | (421.9 M) | ||||
| Working Capital | (318 M) | ||||
| Current Asset | 609 M | ||||
| Current Liabilities | 626.6 M | ||||
| Net Asset | 2.75 B |
About Calumet Specialty Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calumet Specialty Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calumet Specialty using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calumet Specialty Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.